Latest Industry Insights

To understand how microarray technology is evolving to meet growing scientific demands, Technology Networks spoke with Thermo Fisher Scientific’s Ravi Gupta and Dr. Robert Balog.

Dr. De Leoz provides unique perspectives on the trends that are shaping, and will continue to shape, the food analysis landscape.

In this Q&A, Pratt discusses a recent study comparing multiplex droplet digital PCR (ddPCR) with traditional quantitative PCR (qPCR), highlighting key methodological differences, assay validation strategies and the advantages of ddPCR.

Technology Networks spoke with Dr. Olga Colgan and Dr. Joseph Chiweshe to learn how AI-driven digital pathology is reshaping diagnostic workflows.

Deep Visual Proteomics integrates high-resolution imaging, AI and ultra-sensitive mass spectrometry to map proteins at single-cell resolution while preserving spatial context.

In this interview, Dr. Denise Teber, a scientific expert in molecular biology at Charles River Laboratories, discusses how ddPCR is being used to improve contamination risk management.

In the heart of Cambridge, a quiet revolution is reshaping the way science startups scale: one built not only on breakthrough molecules and patents, but also on collaborative spaces, shared values and pragmatic support.

We spoke with Castle Bioscience's Dr. Rebecca Critchley-Thorne about AI-enabled spatial proteomics, TissueCypher’s impact on Barrett’s esophagus management and its broader potential for precision oncology.

Learn how scientists mapped the protein landscape of toxic epidermal necrolysis, a lethal skin disease, a lethal skin disease, by applying Deep Visual Proteomics, leading to the use of JAK inhibitors with life-saving results.

As global scientific and regulatory landscapes shift, companies across the life sciences sector are under growing pressure to adapt. Hear how Phenomenex are taking a proactive approach.